Kr Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 18.25 Cr
as on 16-11-2024
- Paid Up Capital ₹ 18.10 Cr
as on 16-11-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 291.75 Cr
as on 16-11-2024
- Revenue 12.42%
(FY 2023)
- Profit -12.33%
(FY 2023)
- Ebitda -7.60%
(FY 2023)
- Net Worth 4.31%
(FY 2023)
- Total Assets 11.11%
(FY 2023)
About Kr Lifesciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 18.25 Cr and a paid-up capital of Rs 18.10 Cr.
The company currently has active open charges totaling ₹291.75 Cr.
Vandan Churiwal, Atul Churiwal, and Sangita Churiwal serve as directors at the Company.
- CIN/LLPIN
U01100WB2020PTC242314
- Company No.
242314
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Kr Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vandan Churiwal  | Director | 30-Dec-2020 | Current |
| Atul Churiwal | Director | 30-Dec-2020 | Current |
| Sangita Churiwal | Whole-Time Director | 30-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Kr Lifesciences.
Kr Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.42% increase. The company also saw a substantial fall in profitability, with a 12.33% decrease in profit. The company's net worth moved up by a moderate rise of 4.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kr Lifesciences?
In 2023, Kr Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Truly Pest Solution Private LimitedActive 15 years 6 monthsAtul Churiwal and Sangita Churiwal are mutual person
Krishi Rasayan Exports Pvt.Ltd.Active 29 years 2 monthsVandan Churiwal and Atul Churiwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Jul 2024 | ₹0.50 M | Open |
Citi Bank N.A. Creation Date: 28 Jun 2024 | ₹20.00 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Jun 2024 | ₹0.50 M | Open |
How Many Employees Work at Kr Lifesciences?
Kr Lifesciences has a workforce of 311 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kr Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kr Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
